JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB18180

Anti-ABCA1 antibody [AB.H10]

4

(18 Reviews)

|

(244 Publications)

Anti-ABCA1 antibody [AB.H10] (ab18180) is a mouse monoclonal antibody detecting ABCA1 in Western Blot, Flow Cytometry, IHC-P. Suitable for Human, Mouse.

- KO validated for confirmed specificity
- Over 200 publications
- Trusted since 2005

View Alternative Names

ABC1, CERP, ABCA1, Phospholipid-transporting ATPase ABCA1, ATP-binding cassette sub-family A member 1, ATP-binding cassette transporter 1, Cholesterol efflux regulatory protein, ABC-1, ATP-binding cassette 1

8 Images
Flow Cytometry - Anti-ABCA1 antibody [AB.H10] (AB18180)
  • Flow Cyt

Unknown

Flow Cytometry - Anti-ABCA1 antibody [AB.H10] (AB18180)

Overlay histogram showing HepG2 cells stained with ab18180 (red line). The cells were fixed with methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab18180, 2μg/1x106 cells) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was mouse IgG1 [ICIGG1] (ab91353, 2μg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed. This antibody gave a positive signal in HepG2 cells fixed with 4% paraformaldehyde/permeabilized in 0.1% PBS-Tween used under the same conditions.

Western blot - Anti-ABCA1 antibody [AB.H10] (AB18180)
  • WB

Supplier Data

Western blot - Anti-ABCA1 antibody [AB.H10] (AB18180)

The lower bands are from the secondary anti-mouse antibody reacting to the endogenous mouse antibodies from the tissue.

All lanes:

Western blot - Anti-ABCA1 antibody [AB.H10] (ab18180) at 1/1000 dilution

Lanes 1, 3 and 5:

Wild type mouse liver tissue lysate at 100 µg

Lanes 2, 4 and 6:

Knockout mouse liver tissue lysate at 100 µg

Predicted band size: 254 kDa

Observed band size: 254 kDa

false

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ABCA1 antibody [AB.H10] (AB18180)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ABCA1 antibody [AB.H10] (AB18180)

Immunoreactivity of pancreas tissue for ABCA1 protein. Left panel : strong immunopositivity of exocrine glandular cells of the pancreas, especially in the basal region (arrows). Interstitial microvascular cells are apparently negative. Cells within the islet were weakly positive (data not shown). Right panel : the negative control. Hematoxylin counterstain.

Western blot - Anti-ABCA1 antibody [AB.H10] (AB18180)
  • WB

CiteAb

Western blot - Anti-ABCA1 antibody [AB.H10] (AB18180)

Western Blotting using Anti-ABCA1 antibody [AB.H10]Anti-ABCA1 antibody [AB.H10], ab18180. Publication image from Rao, G. N. et al., 2015, Nat Commun, 26104863. Legend direct from paper.

The lack of Pak1 diminishes monocyte adhesion to the aorta.(a) Aortas from 24-week-old ApoE−/− mice were incubated with BCECF-labelled monocytes from C57BL/6 and Pak1−/− mice, and the adherent monocytes were observed under a fluorescent microscope and counted. (b) Aortas from ApoE−/− and ApoE−/− : Pak1−/− mice fed with WD for 16 weeks were incubated with BCECF-labelled monocytes from C57BL/6 mice and the adherent cells were observed under a fluorescent microscope and counted. (c) Peritoneal macrophages from WT, ApoE−/− and Pak1−/− mice were treated with and without cholesterol (40 µg ml−1), IL-6 (20 ng ml−1) or MCP-1 (50 ng ml−1) for 6 h and cell extracts were prepared. Equal amounts of protein from control and each treatment were analysed by western blotting for CD36 and ABCA1 levels using their specific antibodies and normalized for β-tubulin. Bar graphs in a and b represent three independent experiments with three mice per group per experiment. Data were presented as mean±s.d. and assessed by Student's t-test. *P<0.01 versus WT or ApoE−/− mice. Scale bars, 20 µm (a,b).

false

Western blot - Anti-ABCA1 antibody [AB.H10] (AB18180)
  • WB

CiteAb

Western blot - Anti-ABCA1 antibody [AB.H10] (AB18180)

Western Blotting using Anti-ABCA1 antibody [AB.H10]Anti-ABCA1 antibody [AB.H10], ab18180. Publication image from Rao, G. N. et al., 2015, Nat Commun, 26104863. Legend direct from paper.

Pak1 regulates SMC migration and lesion formation.Aortic SMCs from ApoE−/− and ApoE−/− : Pak1−/− mice fed with WD for 16 weeks were isolated, cultured and tested for their purity using anti-SMCα-actin antibodies (a), analysed for IL-6 expression by FACS (b) and subjected to wound-healing migration assay (c). (d) Aortic SMC extracts from ApoE−/− and ApoE−/− : Pak1−/− mice were analysed by western blotting for the indicated proteins using their specific antibodies. FACS analysis of CD36 expression (e) and Dil-OxLDL uptake (f) are shown. SMCs isolated from ApoE−/− and ApoE−/− : Pak1−/− mice fed with WD for 16 weeks were either incubated with OxLDL or Dil-OxLDL for 6 h and stained with Oil red O (g, left panel) or observed under fluorescent microscope (g, right panel), or subjected to cholesterol efflux (h) as described in Methods. (i) Extracts of SMCs isolated from WT, Pak1−/− and ApoE−/− mice fed with CD were analysed by western blotting for the indicated proteins using their specific antibodies. (j) SMCs from WT and Pak1−/− mice fed with CD were treated with OxLDL (10 µg ml−1) for the indicated time periods and RNA was isolated and analysed by qRT–PCR for IL-6 and MCP-1 levels. Bar graph in c represents quantification of three independent experiments. Bar graph in d represents the quantification of three western blottings each from a group of two pooled arteries. Data were presented as mean±s.d. and assessed by Student's t-test. *P<0.01 versus ApoE−/− mice; †P<0.01 versus WT vehicle control; #P<0.01 versus WT mice+OxLDL. Scale bars, 50 µm (a) and 100 and 50 µm (g, left and right panels, respectively).

false

Western blot - Anti-ABCA1 antibody [AB.H10] (AB18180)
  • WB

CiteAb

Western blot - Anti-ABCA1 antibody [AB.H10] (AB18180)

Western Blotting using Anti-ABCA1 antibody [AB.H10]Anti-ABCA1 antibody [AB.H10], ab18180. Publication image from Rao, G. N. et al., 2015, Nat Commun, 26104863. Legend direct from paper.

Pak1 regulates SMC migration and lesion formation.Aortic SMCs from ApoE−/− and ApoE−/− : Pak1−/− mice fed with WD for 16 weeks were isolated, cultured and tested for their purity using anti-SMCα-actin antibodies (a), analysed for IL-6 expression by FACS (b) and subjected to wound-healing migration assay (c). (d) Aortic SMC extracts from ApoE−/− and ApoE−/− : Pak1−/− mice were analysed by western blotting for the indicated proteins using their specific antibodies. FACS analysis of CD36 expression (e) and Dil-OxLDL uptake (f) are shown. SMCs isolated from ApoE−/− and ApoE−/− : Pak1−/− mice fed with WD for 16 weeks were either incubated with OxLDL or Dil-OxLDL for 6 h and stained with Oil red O (g, left panel) or observed under fluorescent microscope (g, right panel), or subjected to cholesterol efflux (h) as described in Methods. (i) Extracts of SMCs isolated from WT, Pak1−/− and ApoE−/− mice fed with CD were analysed by western blotting for the indicated proteins using their specific antibodies. (j) SMCs from WT and Pak1−/− mice fed with CD were treated with OxLDL (10 µg ml−1) for the indicated time periods and RNA was isolated and analysed by qRT–PCR for IL-6 and MCP-1 levels. Bar graph in c represents quantification of three independent experiments. Bar graph in d represents the quantification of three western blottings each from a group of two pooled arteries. Data were presented as mean±s.d. and assessed by Student's t-test. *P<0.01 versus ApoE−/− mice; †P<0.01 versus WT vehicle control; #P<0.01 versus WT mice+OxLDL. Scale bars, 50 µm (a) and 100 and 50 µm (g, left and right panels, respectively).

false

Western blot - Anti-ABCA1 antibody [AB.H10] (AB18180)
  • WB

CiteAb

Western blot - Anti-ABCA1 antibody [AB.H10] (AB18180)

Western Blotting using Anti-ABCA1 antibody [AB.H10]Anti-ABCA1 antibody [AB.H10], ab18180. Publication image from Fernández-Hernando, C. et al., 2016, Nat Commun, 27460411. Legend direct from paper.

ANGPTL4 deficiency promotes macrophage foam cell formation and apoptosis.(a) Representative pictures from WT and Angptl4−/− mouse peritoneal macrophages incubated with or without Ac- LDL (120 µg ml−1) for 24 h and stained with BODIPY 493/503 (1 µg ml−1) and DAPI (Green and blue, respectively). Scale bar, 5 µm. Quantification of the mean average intensity is in the right panel. (b) Total cholesterol content in peritoneal macrophages isolated from WT and Angptl4−/− mice incubated with or without Ac-LDL (120 µg ml−1) for 24 h. (c) Flow cytometry analysis of DiI-Ox-LDL binding in peritoneal macrophages incubated with DiI-Ox-LDL (30 µg cholesterol per ml) for 30 min at 4 °C. At the end of the incubation period, cells were washed and incubated in RPMI 10% FBS media for 15 min at 37 °C to allow the internalization. (d) Flow cytometry analysis of DiI-Ox-LDL uptake in peritoneal macrophages incubated with DiI-Ox-LDL (30 µg cholesterol per ml) for 2 h at 37 °C. The results are expressed in terms of specific MFI after subtracting auto-fluorescence of cells incubated in the absence of DiI-Ox-LDL. (e) Cholesterol efflux to apolipoprotein A1 (ApoA1) in peritoneal macrophages isolated from WT and Angptl4−/− mice stimulated with or without T0901317 (T090). (f) Western blot analysis of indicated proteins in peritoneal macrophages from WT and Angptl4−/− mice incubated with or without Ac-LDL (120 µg ml−1) for 24 h. (g) Western blot analysis (representative of three blots) of ABCA1 expression in WT and Angptl4−/− peritoneal macrophages incubated with Ac-LDL for 24 h. Surface ABCA1 was isolated using biotinylation followed by incubation with neutravidin. HSP90 is used as loading control (f and g). Full scans of westerns blots are provided in Supplementary Fig. 8. (h) Representative confocal images of mouse peritoneal macrophages from WT and Angptl4−/− mice incubated with Ac-LDL for 24 h and stained with cholera toxin B (CTxB), ABCA1 and DAPI. Quantification of co-localization of CTxB and ABCA1 is on the right panel. Scale bar, 10 µm. (i) Representative images of WT and Angptl4−/− macrophages cultured on coverslips and treated with or without Ac-LDL (120 µg ml−1) in combination with ACAT inhibitor (58035) for 24 h to induce lipid-loading-induced apoptosis (scale bars, 200 µm). Apoptosis was detected using Annexin-V staining. Right panel shows the quantification of percentage of apoptotic cells from four random fields from each cover slip. All data represent the mean±s.e.m. from at least three experiments in duplicate; *P<0.05 compared with WT macrophages by unpaired t-test. MFI, median intensity of fluorescence.

false

Western blot - Anti-ABCA1 antibody [AB.H10] (AB18180)
  • WB

CiteAb

Western blot - Anti-ABCA1 antibody [AB.H10] (AB18180)

Western Blotting using Anti-ABCA1 antibody [AB.H10]Anti-ABCA1 antibody [AB.H10], ab18180. Publication image from Fernández-Hernando, C. et al., 2016, Nat Commun, 27460411. Legend direct from paper.

ANGPTL4 deficiency promotes macrophage foam cell formation and apoptosis.(a) Representative pictures from WT and Angptl4−/− mouse peritoneal macrophages incubated with or without Ac- LDL (120 µg ml−1) for 24 h and stained with BODIPY 493/503 (1 µg ml−1) and DAPI (Green and blue, respectively). Scale bar, 5 µm. Quantification of the mean average intensity is in the right panel. (b) Total cholesterol content in peritoneal macrophages isolated from WT and Angptl4−/− mice incubated with or without Ac-LDL (120 µg ml−1) for 24 h. (c) Flow cytometry analysis of DiI-Ox-LDL binding in peritoneal macrophages incubated with DiI-Ox-LDL (30 µg cholesterol per ml) for 30 min at 4 °C. At the end of the incubation period, cells were washed and incubated in RPMI 10% FBS media for 15 min at 37 °C to allow the internalization. (d) Flow cytometry analysis of DiI-Ox-LDL uptake in peritoneal macrophages incubated with DiI-Ox-LDL (30 µg cholesterol per ml) for 2 h at 37 °C. The results are expressed in terms of specific MFI after subtracting auto-fluorescence of cells incubated in the absence of DiI-Ox-LDL. (e) Cholesterol efflux to apolipoprotein A1 (ApoA1) in peritoneal macrophages isolated from WT and Angptl4−/− mice stimulated with or without T0901317 (T090). (f) Western blot analysis of indicated proteins in peritoneal macrophages from WT and Angptl4−/− mice incubated with or without Ac-LDL (120 µg ml−1) for 24 h. (g) Western blot analysis (representative of three blots) of ABCA1 expression in WT and Angptl4−/− peritoneal macrophages incubated with Ac-LDL for 24 h. Surface ABCA1 was isolated using biotinylation followed by incubation with neutravidin. HSP90 is used as loading control (f and g). Full scans of westerns blots are provided in Supplementary Fig. 8. (h) Representative confocal images of mouse peritoneal macrophages from WT and Angptl4−/− mice incubated with Ac-LDL for 24 h and stained with cholera toxin B (CTxB), ABCA1 and DAPI. Quantification of co-localization of CTxB and ABCA1 is on the right panel. Scale bar, 10 µm. (i) Representative images of WT and Angptl4−/− macrophages cultured on coverslips and treated with or without Ac-LDL (120 µg ml−1) in combination with ACAT inhibitor (58035) for 24 h to induce lipid-loading-induced apoptosis (scale bars, 200 µm). Apoptosis was detected using Annexin-V staining. Right panel shows the quantification of percentage of apoptotic cells from four random fields from each cover slip. All data represent the mean±s.e.m. from at least three experiments in duplicate; *P<0.05 compared with WT macrophages by unpaired t-test. MFI, median intensity of fluorescence.

false

Key facts

Host species

Mouse

Clonality

Monoclonal

Clone number

AB.H10

Isotype

IgG1

Carrier free

No

Reacts with

Mouse, Human

Applications

WB, IHC-P, Flow Cyt

applications

Immunogen

Recombinant Fragment Protein within Human ABCA1 aa 1800 to C-terminus. The exact immunogen used to generate this antibody is proprietary information.

O95477

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "FlowCyt-species-checked": "testedAndGuaranteed", "FlowCyt-species-dilution-info": "1-2 µg for 10^6 Cells", "FlowCyt-species-notes": "<p><a href='/en-us/products/primary-antibodies/mouse-igg1-kappa-monoclonal-15-6e10a7-isotype-control-ab170190'>ab170190</a> - Mouse monoclonal IgG1, is suitable for use as an isotype control with this antibody.</p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/200 - 1/500", "WB-species-notes": "<p>Abcam recommends using BSA as the blocking agent and 80-100 ug of lysate.</p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/200", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval before commencing with IHC staining protocol." }, "Mouse": { "FlowCyt-species-checked": "guaranteed", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/200 - 1/500", "WB-species-notes": "<p>Abcam recommends using BSA as the blocking agent and 80-100 ug of lysate.</p>", "IHCP-species-checked": "guaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" } } }

Product details

What is this antibody validated in?
Anti-ABCA1 antibody [AB.H10] (ab18180) is a mouse monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Flow Cyt), Immunohistochemistry (IHC-P) in Human, Mouse samples.

What is the molecular weight of ABCA1?
Anti-ABCA1 [AB.H10] (ab18180) specifically detects a band for ABCA1 (UniProt: O95477) at a molecular weight of 254kDa.

Trusted by the scientific community
Anti-ABCA1 [AB.H10] (ab18180) was first used in a scientific publication in 2005 and has been cited over 200 times in peer-reviewed journals.

Reviewed by scientists
Anti-ABCA1 [AB.H10] (ab18180) has over 15 independent reviews from customers.

Specificity confirmed
The specificity of Anti-ABCA1 antibody [AB.H10] (ab18180) has been confirmed by Western blot testing in ABCA1 Knockout Mouse liver samples.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Purification notes
Protein A purified from TCS
Storage buffer
pH: 7.2 Preservative: 0.05% Sodium azide Constituents: PBS
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The ABCA1 protein also known as ATP-binding cassette transporter A1 plays an important role in lipid transport processes. It helps in the export of cholesterol and phospholipids to apolipoprotein A-I which is essential for high-density lipoprotein (HDL) formation. The ABCA1 molecular weight is approximately 220 kDa. This protein is widely expressed in various tissues including the liver lungs and intestines indicating its systemic role in lipid metabolism. Researchers often study ABCA1 using techniques like ABCA1 ELISA and H10 flow cytometry.
Biological function summary

ABCA1 functions as a cholesterol efflux pump in the cellular membrane. It facilitates the transfer of cholesterol to lipid-poor apolipoproteins such as apoA-I which then forms HDL particles. This active process helps maintain cellular cholesterol homeostasis and reduces cholesterol accumulation. ABCA1 is a critical component of the HDL synthesis pathway and does not form part of a larger protein complex acting more as an individual unit in this function.

Pathways

Many regulatory mechanisms control the activity of ABCA1. It plays a significant role in the reverse cholesterol transport pathway thereby promoting the movement of cholesterol away from peripheral tissues back to the liver for excretion. This pathway helps maintain systemic lipid balance. The LXR/RXR pathway regulates ABCA1 expression aligning it closely with other proteins such as LXR and ABCG1 which also deal with cholesterol metabolism.

ABCA1 is intimately connected with atherosclerosis and Tangier disease. Dysfunction or mutations in the ABCA1 gene lead to impaired cholesterol efflux contributing to cholesterol build-up and atherosclerotic plaque formation. Tangier disease a rare genetic disorder arises from severe mutations in ABCA1 resulting in very low levels of HDL cholesterol. This protein's role in disease is often studied alongside proteins such as apoA-I and LDL receptors which influence cholesterol transportation and storage.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Catalyzes the translocation of specific phospholipids from the cytoplasmic to the extracellular/lumenal leaflet of membrane coupled to the hydrolysis of ATP (PubMed : 24097981, PubMed : 35974019). Thereby, participates in phospholipid transfer to apolipoproteins to form nascent high density lipoproteins/HDLs (PubMed : 14754908). Transports preferentially phosphatidylcholine over phosphatidylserine (PubMed : 24097981). May play a similar role in the efflux of intracellular cholesterol to apolipoproteins and the formation of nascent high density lipoproteins/HDLs (PubMed : 10533863, PubMed : 14754908, PubMed : 24097981, PubMed : 35974019). Translocates phospholipids from the outer face of the plasma membrane and forces it through its gateway and annulus into an elongated hydrophobic tunnel in its extracellular domain (PubMed : 35974019).
See full target information ABCA1

Publications (244)

Recent publications for all applications. Explore the full list and refine your search

Nature communications 16:8077 PubMed40883260

2025

UBE3A promotes foam cell formation and counters remyelination by targeting ABCA1 for proteasomal degradation.

Applications

Unspecified application

Species

Unspecified reactive species

Melanie Loix,Sam Vanherle,Laura Bolkaerts,Sanne G S Verberk,Mattijs Punt,Flore Wouters,Brecht Moonen,Rob Verhagen,Suzanne A E Van Wouw,Aldo Jongejan,Ben Distel,Ype Elgersma,Mansour Haidar,Noam Zelcer,Jerome J A Hendriks,Jeroen F J Bogie

Journal of atherosclerosis and thrombosis : PubMed40850750

2025

Enhancement of ABCA1 and ABCG1 Expression and Cholesterol Efflux by a Metabolite of Tipelukast: A Potential Therapeutic Strategy for Atherosclerosis.

Applications

Unspecified application

Species

Unspecified reactive species

Huicheng Qi,Masatsune Ogura,Kazuko Matsuda,Takashi Miida

Food & nutrition research 69: PubMed40475061

2025

Protective effect of water extract and its main compound, Cycloalliin, on foam cell formation in THP-1-derived macrophages.

Applications

Unspecified application

Species

Unspecified reactive species

Ha-Rin Moon,Jung-Mi Yun

Mechanobiology in medicine 3:100129 PubMed40395775

2025

Overstretch causes lipid accumulation in vascular smooth muscle cells dependent on NADPH oxidase 1.

Applications

Unspecified application

Species

Unspecified reactive species

Jiazhen Zhang,Qinfen Li,Suoqi Ding,Wei Xu,Jilei Su,Jingang Cui,Yongsheng Ding

Nutrients 17: PubMed40292571

2025

Protocatechuic Acid Attenuates Inflammation in Macrophage-like Vascular Smooth Muscle Cells in ApoE Mice.

Applications

Unspecified application

Species

Unspecified reactive species

Shuangshuang Li,Yushi Du,Guanyu Chen,Yihui Mao,Wenyu Zhang,Mengxi Kang,Shasha Zhu,Dongliang Wang

Cell death discovery 11:193 PubMed40268915

2025

High-fat diet promotes lipotoxicity in the podocytes of uninephrectomized mice: a targeted lipidomics and kidney podocyte-specific analysis.

Applications

Unspecified application

Species

Unspecified reactive species

Se-Hyun Oh,You-Jin Kim,Subin Bae,Hee-Yeon Jung,So-Young Park,Jeong-Hoon Lim,Jang-Hee Cho,Chan-Duck Kim,Sun-Hee Park,Tae-Hwan Kwon,Yong-Jin Kim,Kwang-Hyeon Liu,Yong-Lim Kim

Cellular and molecular life sciences : CMLS 82:131 PubMed40137979

2025

Microglia regulate myelin clearance and cholesterol metabolism after demyelination via interferon regulatory factor 5.

Applications

Unspecified application

Species

Unspecified reactive species

Alejandro Montilla,Alazne Zabala,Ibai Calvo,Marina Bosch-Juan,Irene Tomé-Velasco,Paloma Mata,Mirjam Koster,Amanda Sierra,Susanne M Kooistra,Federico N Soria,Bart J L Eggen,Olatz Fresnedo,José Andrés Fernández,Vanja Tepavcevic,Carlos Matute,María Domercq

Molecular neurodegeneration 20:15 PubMed39901180

2025

Cellular senescence induced by cholesterol accumulation is mediated by lysosomal ABCA1 in APOE4 and AD.

Applications

Unspecified application

Species

Unspecified reactive species

Shaowei Wang,Boyang Li,Jie Li,Zhiheng Cai,Cristelle Hugo,Yi Sun,Lu Qian,Julia Tcw,Helena C Chui,Dante Dikeman,Isaac Asante,Stan G Louie,David A Bennett,Zoe Arvanitakis,Alan T Remaley,Bilal E Kerman,Hussein N Yassine

British journal of pharmacology 182:1763-1782 PubMed39843165

2025

Activating transcription factor-3 orchestrates the modulation of vascular anti-contractile activity and relaxation by governing the secretion of HDL-bound sphingosine-1-phosphate in perivascular adipose tissue.

Applications

Unspecified application

Species

Unspecified reactive species

Hsiao-Fen Li,Heng Lin,Hsin-Tzu Liu,Tsung-Jen Lin,Tzu-Ling Tseng

Redox biology 78:103427 PubMed39566163

2024

Fluorescent gold nanoclusters possess multiple actions against atherosclerosis.

Applications

Unspecified application

Species

Unspecified reactive species

Yi-Nan Lee,Yih-Jer Wu,Cheng-Huang Su,Bo-Jeng Wang,Sheng-Hsun Yang,Hsin-I Lee,Yen-Hung Chou,Ting-Yi Tien,Chao-Feng Lin,Wen-Hsiung Chan,Ching-Hu Chung,Shin-Wei Wang,Hung-I Yeh
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com